The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rosuvastatin Drugs Market Research Report 2025
Synopsis
Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks.
The global Rosuvastatin Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rosuvastatin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin Drugs.
Report Scope
The Rosuvastatin Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rosuvastatin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rosuvastatin Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Watson
ANGITA
Sun Pharmaceutical Industries
Segment by Type
5 mg Tablet
10 mg Tablet
20 mg Tablet
40 mg Tablet
Segment by Application
Hyperlipidemia And Mixed Dyslipidemia
Familial Hypercholesterolemia
Hypertriglyceridemia
Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Atherosclerosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rosuvastatin Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks.
The global Rosuvastatin Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rosuvastatin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin Drugs.
Report Scope
The Rosuvastatin Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rosuvastatin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rosuvastatin Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Watson
ANGITA
Sun Pharmaceutical Industries
Segment by Type
5 mg Tablet
10 mg Tablet
20 mg Tablet
40 mg Tablet
Segment by Application
Hyperlipidemia And Mixed Dyslipidemia
Familial Hypercholesterolemia
Hypertriglyceridemia
Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Atherosclerosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rosuvastatin Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rosuvastatin Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.2.4 20 mg Tablet
1.2.5 40 mg Tablet
1.3 Market by Application
1.3.1 Global Rosuvastatin Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hyperlipidemia And Mixed Dyslipidemia
1.3.3 Familial Hypercholesterolemia
1.3.4 Hypertriglyceridemia
1.3.5 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
1.3.6 Atherosclerosis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rosuvastatin Drugs Market Perspective (2019-2030)
2.2 Rosuvastatin Drugs Growth Trends by Region
2.2.1 Global Rosuvastatin Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rosuvastatin Drugs Historic Market Size by Region (2019-2024)
2.2.3 Rosuvastatin Drugs Forecasted Market Size by Region (2025-2030)
2.3 Rosuvastatin Drugs Market Dynamics
2.3.1 Rosuvastatin Drugs Industry Trends
2.3.2 Rosuvastatin Drugs Market Drivers
2.3.3 Rosuvastatin Drugs Market Challenges
2.3.4 Rosuvastatin Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rosuvastatin Drugs Players by Revenue
3.1.1 Global Top Rosuvastatin Drugs Players by Revenue (2019-2024)
3.1.2 Global Rosuvastatin Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Rosuvastatin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rosuvastatin Drugs Revenue
3.4 Global Rosuvastatin Drugs Market Concentration Ratio
3.4.1 Global Rosuvastatin Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rosuvastatin Drugs Revenue in 2023
3.5 Rosuvastatin Drugs Key Players Head office and Area Served
3.6 Key Players Rosuvastatin Drugs Product Solution and Service
3.7 Date of Enter into Rosuvastatin Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rosuvastatin Drugs Breakdown Data by Type
4.1 Global Rosuvastatin Drugs Historic Market Size by Type (2019-2024)
4.2 Global Rosuvastatin Drugs Forecasted Market Size by Type (2025-2030)
5 Rosuvastatin Drugs Breakdown Data by Application
5.1 Global Rosuvastatin Drugs Historic Market Size by Application (2019-2024)
5.2 Global Rosuvastatin Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rosuvastatin Drugs Market Size (2019-2030)
6.2 North America Rosuvastatin Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rosuvastatin Drugs Market Size by Country (2019-2024)
6.4 North America Rosuvastatin Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rosuvastatin Drugs Market Size (2019-2030)
7.2 Europe Rosuvastatin Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rosuvastatin Drugs Market Size by Country (2019-2024)
7.4 Europe Rosuvastatin Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rosuvastatin Drugs Market Size (2019-2030)
8.2 Asia-Pacific Rosuvastatin Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rosuvastatin Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Rosuvastatin Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rosuvastatin Drugs Market Size (2019-2030)
9.2 Latin America Rosuvastatin Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rosuvastatin Drugs Market Size by Country (2019-2024)
9.4 Latin America Rosuvastatin Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rosuvastatin Drugs Market Size (2019-2030)
10.2 Middle East & Africa Rosuvastatin Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rosuvastatin Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Rosuvastatin Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Rosuvastatin Drugs Introduction
11.1.4 AstraZeneca Revenue in Rosuvastatin Drugs Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Watson
11.2.1 Watson Company Detail
11.2.2 Watson Business Overview
11.2.3 Watson Rosuvastatin Drugs Introduction
11.2.4 Watson Revenue in Rosuvastatin Drugs Business (2019-2024)
11.2.5 Watson Recent Development
11.3 ANGITA
11.3.1 ANGITA Company Detail
11.3.2 ANGITA Business Overview
11.3.3 ANGITA Rosuvastatin Drugs Introduction
11.3.4 ANGITA Revenue in Rosuvastatin Drugs Business (2019-2024)
11.3.5 ANGITA Recent Development
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Detail
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Rosuvastatin Drugs Business (2019-2024)
11.4.5 Sun Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Rosuvastatin Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 5 mg Tablet
Table 3. Key Players of 10 mg Tablet
Table 4. Key Players of 20 mg Tablet
Table 5. Key Players of 40 mg Tablet
Table 6. Global Rosuvastatin Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Rosuvastatin Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Rosuvastatin Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Rosuvastatin Drugs Market Share by Region (2019-2024)
Table 10. Global Rosuvastatin Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Rosuvastatin Drugs Market Share by Region (2025-2030)
Table 12. Rosuvastatin Drugs Market Trends
Table 13. Rosuvastatin Drugs Market Drivers
Table 14. Rosuvastatin Drugs Market Challenges
Table 15. Rosuvastatin Drugs Market Restraints
Table 16. Global Rosuvastatin Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Rosuvastatin Drugs Market Share by Players (2019-2024)
Table 18. Global Top Rosuvastatin Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosuvastatin Drugs as of 2023)
Table 19. Ranking of Global Top Rosuvastatin Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Rosuvastatin Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Rosuvastatin Drugs Product Solution and Service
Table 23. Date of Enter into Rosuvastatin Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rosuvastatin Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Rosuvastatin Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Rosuvastatin Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Rosuvastatin Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Rosuvastatin Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Rosuvastatin Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Rosuvastatin Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Rosuvastatin Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Rosuvastatin Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Rosuvastatin Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Rosuvastatin Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Rosuvastatin Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Rosuvastatin Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Rosuvastatin Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Rosuvastatin Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Rosuvastatin Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rosuvastatin Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rosuvastatin Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Rosuvastatin Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Rosuvastatin Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. AstraZeneca Company Detail
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Rosuvastatin Drugs Product
Table 51. AstraZeneca Revenue in Rosuvastatin Drugs Business (2019-2024) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. Watson Company Detail
Table 54. Watson Business Overview
Table 55. Watson Rosuvastatin Drugs Product
Table 56. Watson Revenue in Rosuvastatin Drugs Business (2019-2024) & (US$ Million)
Table 57. Watson Recent Development
Table 58. ANGITA Company Detail
Table 59. ANGITA Business Overview
Table 60. ANGITA Rosuvastatin Drugs Product
Table 61. ANGITA Revenue in Rosuvastatin Drugs Business (2019-2024) & (US$ Million)
Table 62. ANGITA Recent Development
Table 63. Sun Pharmaceutical Industries Company Detail
Table 64. Sun Pharmaceutical Industries Business Overview
Table 65. Sun Pharmaceutical Industries Rosuvastatin Drugs Product
Table 66. Sun Pharmaceutical Industries Revenue in Rosuvastatin Drugs Business (2019-2024) & (US$ Million)
Table 67. Sun Pharmaceutical Industries Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rosuvastatin Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rosuvastatin Drugs Market Share by Type: 2023 VS 2030
Figure 3. 5 mg Tablet Features
Figure 4. 10 mg Tablet Features
Figure 5. 20 mg Tablet Features
Figure 6. 40 mg Tablet Features
Figure 7. Global Rosuvastatin Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Rosuvastatin Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hyperlipidemia And Mixed Dyslipidemia Case Studies
Figure 10. Familial Hypercholesterolemia Case Studies
Figure 11. Hypertriglyceridemia Case Studies
Figure 12. Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Case Studies
Figure 13. Atherosclerosis Case Studies
Figure 14. Others Case Studies
Figure 15. Rosuvastatin Drugs Report Years Considered
Figure 16. Global Rosuvastatin Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Rosuvastatin Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Rosuvastatin Drugs Market Share by Region: 2023 VS 2030
Figure 19. Global Rosuvastatin Drugs Market Share by Players in 2023
Figure 20. Global Top Rosuvastatin Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosuvastatin Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Rosuvastatin Drugs Revenue in 2023
Figure 22. North America Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Rosuvastatin Drugs Market Share by Country (2019-2030)
Figure 24. United States Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Rosuvastatin Drugs Market Share by Country (2019-2030)
Figure 28. Germany Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Rosuvastatin Drugs Market Share by Region (2019-2030)
Figure 36. China Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Rosuvastatin Drugs Market Share by Country (2019-2030)
Figure 44. Mexico Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Rosuvastatin Drugs Market Share by Country (2019-2030)
Figure 48. Turkey Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Rosuvastatin Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. AstraZeneca Revenue Growth Rate in Rosuvastatin Drugs Business (2019-2024)
Figure 51. Watson Revenue Growth Rate in Rosuvastatin Drugs Business (2019-2024)
Figure 52. ANGITA Revenue Growth Rate in Rosuvastatin Drugs Business (2019-2024)
Figure 53. Sun Pharmaceutical Industries Revenue Growth Rate in Rosuvastatin Drugs Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
